Clofazimine does not lead to significant QT interval prolongation: a multicentre study

Zweijpfenning, S.M.H. (Sanne M H), van Groningen, H. (Hester), J. van Ingen (Jakko), C. Magis-Escurra (Cecile), M. Boeree (Martin), D. Wagner (Dirk), H.I. Bax (Hannelore), Andrejak, C. (Claire), Wener, R. (Reinier), Rahman, A. (Ananna), et al. Hoefsloot, W. (Wouter)

2018-11-01

Additional Metadata
Persistent URL	doi.org/10.1183/13993003.01386-2018, hdl.handle.net/1765/111895
Journal	The European Respiratory Journal
Rights	no subscription
Organisation	Department of Internal Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Zweijpfenning, S.M.H. (Sanne M H), van Groningen, H. (Hester), van Ingen, J., Magis-Escurra, C., Boeree, M., Wagner, D., … Hoefsloot, W. (Wouter). (2018). Clofazimine does not lead to significant QT interval prolongation: a multicentre study. The European Respiratory Journal, 52(5). doi:10.1183/13993003.01386-2018

Publication